Personalized Immunotherapy Treatment Strategies for a Dynamical System of Chronic Myelogenous Leukemia.

Simple Summary: As computer performance continues to grow at more affordable costs, mathematical modelling and in silico experimentation begin to play a larger role in understanding cancer evolution. The aim of our work is to formulate a control strategy for the Adaptive Cellular Therapy (ACT) that...

Descripción completa

Detalles Bibliográficos
Publicado en:Cancers Vol. 13; no. 9; pp. 2030 - 2031
Autores principales: Valle, Paul A., Coria, Luis N., Plata, Corina, Pérez-García, Víctor M., de Pillis, Lisette, Altrock, Philipp, Rockne, Russell
Formato: equations & formulas research tables/charts Journal Article
Publicado: MDPI May2021
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=150367794&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 150367794
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        20726694
        B74B
      jtl: Cancers
      issn: 20726694
      maglogo: N
    pubinfo:
      dt: May2021
      vid: 13
      iid: 9
      pid: 97109
      pub: MDPI
    artinfo:
      ui:
        150367794
        150367794
        150367794
        10.3390/cancers13092030
        150367794
      ppf: 2030
      ppct: 1
      formats:
      tig:
        atl: Personalized Immunotherapy Treatment Strategies for a Dynamical System of Chronic Myelogenous Leukemia.
      aug:
        au:
          Valle, Paul A.
          Coria, Luis N.
          Plata, Corina
          Pérez-García, Víctor M.
          de Pillis, Lisette
          Altrock, Philipp
          Rockne, Russell
        affil: Postgraduate Program in Engineering Sciences, BioMath Research Group, Tecnológico Nacional de México/IT Tijuana, Blvd. Alberto Limón Padilla s/n, Mesa de Otay, Tijuana 22500, Mexico
      sug:
        subj:
          Immunotherapy Methods
          Mathematics
          Leukemia, Myeloid, Chronic
          Human
          Theory
          Leukemia, Myeloid, Chronic Metabolism
          Computer Simulation
          Cell Line, Tumor
          T Lymphocytes
          Cell Death
      ab: Simple Summary: As computer performance continues to grow at more affordable costs, mathematical modelling and in silico experimentation begin to play a larger role in understanding cancer evolution. The aim of our work is to formulate a control strategy for the Adaptive Cellular Therapy (ACT) that can fully eradicates the Chronic Myelogenous Leukemia (CML) cells population in a mathematical model describing interactions between naive T cells, effector T cells and CML cancer cells in the circulatory blood system. Mathematical analysis and numerical simulations allow us to conclude that it is possible to design a personalized administration protocol for the ACT in the form of a pulse train with asymmetrical waves and a fixed amplitude to achieve complete CML cancer cells eradication. The amplitude of the impulse on which the treatment is applied is given by an arithmetical combination of the parameters of the system with at least a duty cycle of 45 min/day. This paper is devoted to exploring personalized applications of cellular immunotherapy as a control strategy for the treatment of chronic myelogenous leukemia described by a dynamical system of three first-order ordinary differential equations. The latter was achieved by applying both the Localization of Compact Invariant Sets and Lyapunov's stability theory. Combination of these two approaches allows us to establish sufficient conditions on the immunotherapy treatment parameter to ensure the complete eradication of the leukemia cancer cells. These conditions are given in terms of the system parameters and by performing several in silico experimentations, we formulated a protocol for the therapy application that completely eradicates the leukemia cancer cells population for different initial tumour concentrations. The formulated protocol does not dangerously increase the effector T cells population. Further, complete eradication is considered when solutions go below a finite critical value below which cancer cells cannot longer persist; i.e., one cancer cell. Numerical simulations are consistent with our analytical results.
      pubtype: Academic Journal
      doctype:
        equations & formulas
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N